Cannara Biotech Inc.
LOVFF
$1.18
-$0.05-3.67%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.51% | 98.41% | 190.28% | 8.60% | 20.91% |
| Total Depreciation and Amortization | 25.91% | -18.99% | 5.54% | -4.60% | 30.69% |
| Total Amortization of Deferred Charges | -82.37% | -- | -- | -- | 8.28% |
| Total Other Non-Cash Items | 129.27% | 224.74% | -73.39% | 40.32% | -159.94% |
| Change in Net Operating Assets | -4,387.82% | 173.72% | -1,764.72% | 108.08% | 106.06% |
| Cash from Operations | -11.43% | 211.50% | -186.62% | 639.66% | 7.39% |
| Capital Expenditure | -196.78% | 30.62% | -23.18% | 56.44% | 73.04% |
| Sale of Property, Plant, and Equipment | 1,115.48% | -99.27% | -- | -38.89% | -90.31% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.18% | 36.27% | 52.89% | 11.41% | -5.16% |
| Cash from Investing | -184.55% | -119.28% | -21.95% | 57.37% | 73.77% |
| Total Debt Issued | -- | -- | -- | -80.00% | -100.00% |
| Total Debt Repaid | -14.51% | 44.70% | 71.02% | -14.92% | -9.79% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.48% | -217.13% | 32.83% | 33.64% | 43.29% |
| Cash from Financing | -2.16% | -123.32% | 1.27% | -417.61% | -51.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -104.11% | 288.39% | -1,094.99% | 321.53% | 363.79% |